Showing results (1291-1300 of 1,557) with videos related to
Sort By:
Pageof 156
The Journal of Molecular Diagnostics : JMD|February 8, 2019
Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene PanelElin S Gray, Tom Witkowski, Michelle Pereira, et al.Analytical Chemistry|February 15, 2017
Leveraging Gas-Phase Fragmentation Pathways for Improved Identification and Selective Detection of Targets Modified by Covalent ProbesScott B Ficarro, Christopher M Browne, Joseph D Card, et al.Elife|March 26, 2019
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell modelsM Catarina Silva, Fleur M Ferguson, Quan Cai, et al.Journal of Medicinal Chemistry|July 8, 2010
A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-AblHwan Geun Choi, Pingda Ren, Francisco Adrian, et al.Molecular Oncology|October 13, 2018
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanomaLeslie Calapre, Tindaro Giardina, Cleo Robinson, et al.Bioorganic & Medicinal Chemistry Letters|August 1, 2008
Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinaseWooyoung Hur, Anastasia Velentza, Sungjoon Kim, et al.The Journal of Nutrition|April 6, 2024
Docosahexaenoic Acid Controls Pulmonary Macrophage Lipid Raft Size and InflammationEdward Ross Pennington, Rafia Virk, Meagan D Bridges, et al.Cancer Research|January 9, 2016
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung CancerKatherine R Amato, Shan Wang, Li Tan, et al.Nature Chemical Biology|April 13, 2010
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle functionNicholas Kwiatkowski, Nannette Jelluma, Panagis Filippakopoulos, et al.European Journal of Medicinal Chemistry|November 19, 2013
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesXianming Deng, Jonathan M Elkins, Jinwei Zhang, et al.Pageof 156